CalcMountain

A1C Calculator

Enter your A1C percentage to see your estimated average blood glucose in mg/dL and mmol/L, or enter an average glucose level to estimate the corresponding A1C. Based on the ADAG study formula.

Hemoglobin A1C (HbA1c, or just "A1C") is the gold-standard diabetes marker used in clinical practice. It measures the percentage of hemoglobin proteins in red blood cells that have glucose attached. Because red blood cells live about 120 days, A1C reflects average blood glucose over the past 2-3 months — providing a smoothed view that captures overall glucose control vs. individual finger-stick readings that vary minute-to-minute. The American Diabetes Association uses A1C to diagnose diabetes, monitor glycemic control, and guide treatment decisions.

A1C and average blood glucose are mathematically related via the ADAG (A1C-Derived Average Glucose) formula developed in 2008. An A1C of 6% corresponds to approximately 126 mg/dL average glucose; 7% = 154 mg/dL; 8% = 183 mg/dL; 9% = 212 mg/dL. Converting between the two helps patients connect A1C lab results to the day-to-day glucose readings on home meters or CGMs (continuous glucose monitors).

This calculator converts between A1C percentage and estimated average glucose (eAG) in both directions. Use it to interpret lab results in glucose terms (or vice versa), set realistic targets based on glucose monitoring data, and understand the relationship between daily glucose patterns and long-term A1C outcomes. A1C tracking is essential for diabetes management — the ADA target for most adults with diabetes is <7%, though individualized targets may be higher (less stringent) or lower based on age, comorbidities, and risk of hypoglycemia.

Inputs

Results

A1C

7.0%

Avg Glucose

154 mg/dL

Avg Glucose

8.6 mmol/L

Category

Diabetes — Fair Control

A1C Details

MetricValue
A1C7.0%
Est. Avg Glucose (mg/dL)154 mg/dL
Est. Avg Glucose (mmol/L)8.6 mmol/L
CategoryDiabetes — Fair Control
FormulaeAG = 28.7 x A1C - 46.7
Last updated: Reviewed by the CalcMountain editorial team

Formula

ADAG formula (2008, widely adopted standard): eAG (mg/dL) = 28.7 × A1C − 46.7 eAG (mmol/L) = 1.59 × A1C − 2.59 Solving for A1C from eAG: A1C = (eAG + 46.7) / 28.7 Conversion between glucose units: mg/dL × 0.0555 = mmol/L mmol/L / 0.0555 = mg/dL Reference ranges (American Diabetes Association): A1C interpretation: Below 5.7%: Normal 5.7%-6.4%: Prediabetes 6.5% and above: Diabetes diagnosis (confirmed on second test) ADA glycemic targets for most non-pregnant adults with diabetes: A1C: <7% (53 mmol/mol) Preprandial glucose: 80-130 mg/dL Postprandial peak glucose: <180 mg/dL Individualized targets may differ: Tighter (A1C <6.5%): younger, healthier, longer life expectancy, low hypoglycemia risk Looser (A1C <8%): older, multiple comorbidities, limited life expectancy, hypoglycemia history Example: A1C of 7.0%. eAG = 28.7 × 7.0 − 46.7 = 200.9 − 46.7 = 154.2 mg/dL Or 8.6 mmol/L (154 × 0.0555) Average glucose of 154 corresponds to A1C of 7%. Reverse: Average glucose of 180 mg/dL. A1C = (180 + 46.7) / 28.7 = 226.7 / 28.7 = 7.9% A 180 mg/dL average corresponds to A1C of 7.9% — above ADA target. Suggests need for treatment intensification.

How to use this calculator

  1. Select conversion direction (A1C → glucose or glucose → A1C).
  2. For A1C → glucose: enter your A1C percentage (typically 4-15% range for diabetes/prediabetes population).
  3. For glucose → A1C: enter your average glucose in mg/dL (typically 80-300 mg/dL range).
  4. Review the corresponding value and the ADA category.
  5. For diabetes management: compare your A1C to the ADA target (<7% for most adults) or your individualized target set by your doctor.
  6. For glucose monitoring: aim for daily glucose readings that average toward your A1C target. CGM (continuous glucose monitor) provides "time in range" metric that complements A1C.
  7. Track A1C every 3-6 months as recommended by your healthcare provider. More frequent for unstable control or recent treatment changes.
  8. Discuss any A1C above goal with your doctor — treatment intensification (lifestyle changes, medication adjustments) can typically bring A1C down 0.5-2% over 3-6 months.

Worked examples

Well-controlled type 2 diabetes

A1C: 6.5% eAG = 28.7 × 6.5 − 46.7 = 140 mg/dL At goal per ADA target. Continue current treatment. Excellent diabetes management — significantly reduces risk of long-term complications (eye disease, kidney disease, neuropathy, cardiovascular disease).

Newly diagnosed needing intensification

A1C: 9.2% eAG = 28.7 × 9.2 − 46.7 = 217 mg/dL Substantially above goal. Risk of long-term complications is meaningfully elevated. Treatment intensification needed — typically combination therapy (metformin + GLP-1 receptor agonist + SGLT2 inhibitor + lifestyle modifications). Goal: reduce to <7% within 6-12 months. Each 1% reduction in A1C reduces risk of complications by 15-37% (per UK Prospective Diabetes Study).

Prediabetes

A1C: 5.9% eAG = 28.7 × 5.9 − 46.7 = 122 mg/dL In prediabetes range (5.7-6.4%). Significantly elevated risk of developing type 2 diabetes within 5-10 years if no intervention. Evidence-based intervention: Diabetes Prevention Program (DPP) — 5-7% body weight loss + 150 min/week moderate exercise — reduces progression to diabetes by 58% over 3 years. Medication option (metformin) reduces by 31%. Prediabetes is the most important window for intervention. Diabetes once established is harder to reverse than to prevent.

When to use this calculator

Use this calculator when interpreting A1C lab results, setting glucose targets based on A1C goals, planning diabetes management with your healthcare team, or evaluating prediabetes risk and prevention strategies.

This is a clinical tool — not a substitute for medical care. Diabetes diagnosis, treatment selection, target setting, and medication management all require professional medical guidance. Use the calculator for understanding and educational context.

Pair with: BMI calculator (since weight is the most modifiable diabetes risk factor), calorie calculator (for dietary planning), and general health-tracking tools.

A few important points about A1C:

1. **A1C captures averages, not extremes.** Two patients with the same A1C of 7% can have very different glucose patterns — one might have stable readings around 154 mg/dL, the other might fluctuate between 60 and 250. CGM time-in-range metrics complement A1C.

2. **A1C accuracy varies by condition.** Conditions affecting red blood cell turnover (anemia, hemoglobinopathies, recent blood loss, kidney disease) can make A1C unreliable. Fructosamine testing or CGM may be preferred in these cases.

3. **Lower isn't always better.** ACCORD and ADVANCE trials showed that very tight A1C targets (<6.5%) in older adults with longstanding diabetes and cardiovascular disease can increase mortality due to hypoglycemia. Individualization is critical.

4. **Each 1% A1C reduction reduces complications meaningfully.** UKPDS demonstrated that each 1% reduction in A1C reduces microvascular complications by ~37%, MI risk by ~14%, all-cause mortality by ~14%. Even modest improvements have substantial clinical benefit.

5. **Lifestyle interventions are powerful.** Diabetes Prevention Program-style interventions (modest weight loss, regular activity) reduce A1C by 0.5-1.5% in many patients — equivalent to or better than adding a medication.

Common mistakes to avoid

  • Treating A1C as if it captures glucose variability. A1C reflects averages. Two patients with same A1C can have very different time-in-range. Use CGM for variability assessment.
  • Targeting very tight A1C in older adults. Less stringent targets (A1C <8%) are appropriate for older adults with multiple comorbidities or hypoglycemia history.
  • Ignoring prediabetes. 5.7-6.4% A1C is the highest-leverage intervention window. Lifestyle intervention prevents progression to diabetes in most cases.
  • Discontinuing diabetes medications when A1C improves. Improved A1C is the GOAL of treatment — discontinuation often causes rebound. Discuss any medication changes with healthcare provider.
  • Forgetting confounders. Anemia, kidney disease, hemoglobinopathies can produce inaccurate A1C. Alternative measures (fructosamine, CGM) may be needed.
  • Skipping regular A1C testing. ADA recommends every 6 months for well-controlled, every 3 months for those adjusting treatment. Self-monitoring at home doesn't replace lab A1C testing.

Frequently Asked Questions

Sources & further reading

SponsoredShop Top Deals on AmazonSupport CalcMountain — browse top-rated products at no extra cost to you.

Related Calculators